PSUSA/00011084/202503
Submitted by Anonymous (not verified) on 27 January 2026 - 15:07
PSUSA/00011084/202503
Human medicines European public assessment report (EPAR): Cetrotide, cetrorelix, Date of authorisation: 12/04/1999, Revision: 31, Status: Authorised
Submitted by Anonymous (not verified) on 27 January 2026 - 15:00
Human medicines European public assessment report (EPAR): Cetrotide, cetrorelix, Date of authorisation: 12/04/1999, Revision: 31, Status: Authorised
Avian influenza (bird flu)
Submitted by Anonymous (not verified) on 27 January 2026 - 15:00
Avian influenza (bird flu)
PSUSA/00001469/202505
Submitted by Anonymous (not verified) on 27 January 2026 - 14:09
PSUSA/00001469/202505
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 68, Status: Authorised
Submitted by Anonymous (not verified) on 27 January 2026 - 13:35
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 68, Status: Authorised
PSUSA/00010488/202505
Submitted by Anonymous (not verified) on 27 January 2026 - 13:10
PSUSA/00010488/202505
Clinical investigation of medicinal products in the treatment of peripheral-arterial occlusive disease - Scientific guideline
Submitted by Anonymous (not verified) on 27 January 2026 - 12:50
Clinical investigation of medicinal products in the treatment of peripheral-arterial occlusive disease - Scientific guideline
Pharmaceutical quality of inhalation and nasal products - Scientific guideline
Submitted by Anonymous (not verified) on 27 January 2026 - 12:15
Pharmaceutical quality of inhalation and nasal products - Scientific guideline
PSUSA/00002303/202505
Submitted by Anonymous (not verified) on 27 January 2026 - 10:54
PSUSA/00002303/202505
PSUSA/00002037/202506
Submitted by Anonymous (not verified) on 27 January 2026 - 10:48
PSUSA/00002037/202506